[(1) One patent Issued (3/20/12) Lipidomic approaches to determine drug response phenotypes in cardiovascular disease Patent # 8137977, expires 12/10/27
Additionally, BPC-157's pro-angiogenic propertieswhile beneficial for healingraise theoretical concerns about tumor growth
In recent years, research has found that AOD 9604 is not limited to weight loss, but has comprehensive bone protection activities that promote bone formation, inhibit bone resorption, increase bone density, improve bone quality, repair joint cartilage, regulate calcium and phosphorus metabolism, and resist inflammation and oxidation
Mol Cell Biol 24(16): 721424)
This action has been implicated in diseases, including inflammation, cardiovascular disease, mutagenesis and cancer, dementia and the aging process